Blockade of Kv1.3 potassium channel inhibits CD8+ T cell‐mediated neuroinflammation via PD‐1/Blimp‐1 signaling

Kv1.3 potassium channel is considered as a target for the treatment of autoimmune diseases such as multiple sclerosis (MS), since Kv1.3 blockade suppresses memory T cell activation including cytotoxic CD8+ T cells. However, the underlying signaling pathway related to autoimmune CD8+ T cell inhibitio...

Full description

Saved in:
Bibliographic Details
Published inThe FASEB journal Vol. 34; no. 11; pp. 15492 - 15503
Main Authors Zhao, Yipeng, Qiu, Wei, Liu, Junchen, Yuan, Xiaolu, Mao, Wenqian, Yin, Jun, Peng, BiWen, Liu, WanHong, Han, Song, He, XiaoHua
Format Journal Article
LanguageEnglish
Published United States 01.11.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Kv1.3 potassium channel is considered as a target for the treatment of autoimmune diseases such as multiple sclerosis (MS), since Kv1.3 blockade suppresses memory T cell activation including cytotoxic CD8+ T cells. However, the underlying signaling pathway related to autoimmune CD8+ T cell inhibition by Kv1.3 channel in neuroinflammatory diseases remains unclear. We found that ImK, a selective Kv1.3 blocker, reduced auto‐reactive CD8+ T cell infiltration in the spinal cords of experimental autoimmune encephalomyelitis (EAE) rats, an animal model of MS. ImK suppressed transcriptional factor Blimp‐1 expression and reduced the cytotoxicity of CD8+ T cells on neuronal cells. Furthermore, ImK upregulated co‐inhibitory molecule PD‐1 to inhibit B lymphocyte‐induced maturation protein (Blimp‐1) in an IL‐2 independent way. In addition, PD‐1 inhibitor impaired the suppression of ImK on CD8+ T cells and accelerated EAE progression. Our study demonstrated a novel regulatory mechanism of Kv1.3 blockade on modulating CD8+ T cell differentiation through PD‐1/Blimp‐1 signaling. This work expands the understanding of Kv1.3 channel for modulating neuroinflammation.
ISSN:0892-6638
1530-6860
DOI:10.1096/fj.202000861RR